Leading With His Heart - A Conversation with Allan Will (Part 1)

Allan Will is one of the founding architects of the medtech industry. Raised by parents who were outspoken supporters of equality and human rights, his desire to help people, passion for science, and business acumen came together in an early job helping Abbott Labs expand into interventional medicine. Just five years later, he was leading DVI, one of the first atherectomy companies, from a 16-person team to a 600-person powerhouse.

With a leadership style marked by a patient-centric focus, high expectations, relentless questioning, and an emphasis on authenticity, he helped bring forth industry-changing products including the first minimally-invasive solution for mitral valve regurgitation, the first non-drug approach to reduce high blood pressure, and the first clot retriever for ischemic stroke.

Over his 40+ year career, Allan has served as CEO of eight Bay Area venture and private equity-backed startups; visionary and founder of The Foundry; founder or co-founder of 12 companies, including Evalve, Ardian and Concentric Medical; founding general partner at Split Rock Partners; and named inventor on over 30 patents.

While he is proud of all of these accomplishments, he most proud of having mentored countless Bay Area medtech CEOs and in particular, having been honored with the Astia/Deloitte Excellence in Mentoring Award for mentoring women executives.

Don’t miss part 1 of Allan's remarkable story.